Show an ad over header. AMP

AMC says it's running out of cash

AMC, the largest movie exhibitor in North America, said in a regulatory filing Tuesday that given its current cash burn-rate, its existing resources may run out by year's end.

Why it matters: The theater chain warned investors in July that it may not survive the pandemic. The company reopened most of its theaters in August, but with studios delaying major blockbusters, attendance has been abysmal.

Details: While AMC has reopened most of its U.S. theaters, it says it's operating most at 20% to 40% of seating capacity.

  • As of October 9, the company resumed operations at 494 of its 598 theaters. Since then, AMC says it has only sold about 2.2 million tickets — an 85% decline from this time last year.
  • For the remaining theaters that have yet to reopen in states including California, New York, Maryland and Washington, AMC says the company is in touch with local governments, but it remains unclear when reopening will happen.

Be smart: AMC says it has two options moving forward: Borrow more cash or sell more tickets, neither of which will be easy.

  • Most Hollywood studios have moved their blockbusters off the release schedule for the remainder of the year and well into 2021.
  • To boost cash flow, the company says it's exploring a few options, including further negotiations with landlords regarding lease payments, striking joint use agreements with business partners and even potential asset sales.
  • But the theater chain warned that even these options come with risk, and they may not be enough to provide the company with the liquidity it needs to survive the pandemic long-term.

The big picture: The movie industry has been crushed by the pandemic and recent events suggest it's not going to get better any time soon.

  • Cineworld, the parent company of Regal Cinemas, las week said it would temporarily close all of its 663 theaters in the U.S. and the U.K.
  • In doing so, it noted that movie studios weren't sending enough of its biggest films to theaters to lure consumers.
  • Several movie delays have been announced over the past several weeks, including MGM's latest James Bond movie, Warner Bros. "Dunes" and "Wonder Woman 1984."

What's next: AMC says for now it remains committed to staying open.

Go deeper: Movie industry in shambles for foreseeable future

Trump plans to address Joe Biden as “the big guy” in effort to dramatize Hunter Biden emails

Watch for President Trump to address Joe Biden as “the big guy” or “the chairman” at tonight's debate as a way of dramatizing the Hunter Biden emails, Jonathan Swan tells me. Hunter's former business partner Tony Bobulinski is expected to be a Trump debate guest.

The big picture: Trump's advisers universally view the first debate as a catastrophe — evidenced by a sharp plunge in Trump’s public and (more convincingly for them) private polling immediately following the debate.

Keep reading... Show less

Intel shares drop sharply despite mostly solid earnings report

Shares of Intel fell as much 10% in after-hours trading Thursday — after the company posted quarterly revenue and earnings generally in line with expectations.

Why it matters: The chip giant is a bellwether for the PC industry, and small signs of weakness may be playing an outsize role in spooking investors.

Keep reading... Show less

FBI: Russian hacking group "Energetic Bear" stole data after targeting local governments

Energetic Bear, a Russian state-sponsored hacking group, has stolen data from two servers after targeting state and federal government networks in the U.S. since at least September, the FBI and Cybersecurity and Infrastructure Security Agency said on Thursday.

Driving the news: Director of National Intelligence John Ratcliffe announced Wednesday that Iran and Russia had obtained voter registration information that could be used to undermine confidence in the U.S. election system.

Keep reading... Show less

FDA approves Gilead's remdesivir as a coronavirus treatment

Gilead Sciences on Thursday received approval from the Food and Drug Administration for remdesivir, an antiviral treatment that has shown modest results against treating COVID-19.

Why it matters: It's the first and only fully FDA-approved drug in the U.S. for treating the coronavirus.

Keep reading... Show less

How the coronavirus pandemic might end

It's still the early days of the coronavirus pandemic, but history, biology and the knowledge gained from our first nine months with COVID-19 point to how the pandemic might end.

The big picture: Pandemics don't last forever. But when they end, it usually isn't because a virus disappearsor is eliminated. Instead, they can settle into a population, becoming a constant background presence that occasionally flares up in local outbreaks.

Keep reading... Show less

Urban housing prices are on the rise

Data: ATTOM Data Solutions; Chart: Naema Ahmed/Axios

Home prices are rising rapidly across the U.S., according to ATTOM Data Solutions.

Driving the news: ATTOM released its 3Q 2020 figures this week, concluding that 77% of metro areas posted "double-digit annual home price gains." Profit margins rose in 86% of the 103 metropolitan statistical areas studied.

Keep reading... Show less

Podcast: Quibi RIP (2020-2020)

Short-form video streaming app Quibi announced that it will cease operations, just six months after a high-profile launch backed by $1.75 billion in funding from studios and venture capitalists.

Axios Re:Cap digs into what went wrong and what happens next, with REDEF CEO Jason Hirschhorn.

Mayors plan multifront attack on census shutdown

A growing number of mayors are banding together to fight what they consider to be an inaccurate and abruptly curtailed 2020 census, using an arsenal of legal, legislative and congressional efforts.

Why it matters: The outcome may determine whether President Trump or Joe Biden controls the redistricting process, which governs everything from congressional representation and redistricting to funding for schools and Head Start.

Keep reading... Show less



Get Goodhumans in your inbox

Most Read

More Stories